Skip to main content

Twitter LinkedIn Email

About
Pipeline
Products
- DEXTENZA^® (dexamethasone ophthalmic insert)
  - Postsurgical Ocular Inflammation and Pain
  - Ocular Itching Associated with Allergic Conjunctivitis
- ReSure^® Sealant
Investors
Careers
Search

News

Page not found

Sorry, the page you were looking for doesn’t exist or has been moved.

© 2022 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA and ReSure are registered trademarks of Ocular Therapeutix, Inc. PP-US-OTX-0004-V3

Privacy Policy | Terms of Use

The use of this Site is governed by its Terms of Use. The information contained in this Site is for informational purposes only. It is not a substitute for professional medical advice and should not be used to diagnose or treat any medical or health condition.

The contents of this Site are subject to change without notice. Ocular Therapeutix may modify and/or discontinue operation of all or portions of this Site at any time at its sole discretion without notice, and assumes no responsibility to update this Site. Ocular Therapeutix makes no representations or warranties with respect to the use of this Site or any information obtained herein.

As required by California Health & Safety Code Sections 119400-119402, Ocular has developed a comprehensive Compliance Program that is designed to comply with applicable federal and state laws and industry standards relating to the marketing and promotion of our products. To our knowledge as of the date of this declaration, Ocular Therapeutix, Inc. maintains compliance under our Compliance Program, as well as, with California Health & Safety Code sections 119400-119402. To request a copy of this declaration and a copy of Ocular Therapeutix’s Code of Conduct that provides an overview of our Compliance Program, please call 1-877-OTX-HELP.

Top